Kays Sepsis and Septic Shock Notes Flashcards

1
Q

Systemic inflammatory response syndrome symptoms (requires 2 symptoms minimum)

A
  • Temperature lower than 36C or higher than 38
  • Heart rate over 90
  • Respiratory rate greater than 20, or PaCO2 less than CO2
  • WBC greater than 12000, less than 4000, or greater than 10% immature band forms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is SOFA score

A
  • a measure of organ dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sofa score of 2 or higher indicates what

A
  • an overall mortality risk of 10% in a general hospital population
  • new guidelines recommend against quick SOFA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Septic shock

A
  • particular subset of sepsis
  • patients requiring pressers to have mean arterial pressure greater than 65 and serum lactate over 2mmol/L in the absence of hypovolemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gram negative sepsis causing organisms

A
  • E. coli (consider GI trauma, mechanicl barrier)
  • Klebsiella (consider GI trauma, mechanical barrier)
  • P. aeruginosa (mechanical ventilation, hospitalization and burn injury)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gram positive sepsis causing organisms

A
  • Staph

- Enterococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fungi sepsis causing organisms

A
  • C. albicans

- C. glabrata

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LPS endotoxin and gram-negative organisms pathogenesis

A
  • ## LPS causes recruitment of immune cells and releases cytokines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Peptidoglycan activity and gram positive organisms

A
  • S. aureus and S. pyogenes are associated with septic shock
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Effects that bacterial cell walls have on hosts immune cells

A
  • hemodynamic changes and platelet aggregation
  • microvascular thrombis formations in organs
  • increased capillary permeability
  • fluid leakage into the interstitial space
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

macrophages role in sepsis

A
  • remove and destroy bacterial products and produce potent mediators of inflammation (TNFalpha, IL1 )
  • try and remember that I cases fever and activates other cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

IL-6 role in sepsis

A
  • induces elevation in body temp
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neutrophils role in sepsis

A
  • contribute to vascular and tissue injury by releasing oxygen metabolites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Endothelial cells role in sepsis

A
  • key target for inflammatory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Plasma procalcitonin

A
  • less than 0.25 antibiotics strongly discouraged

- greater than 1 strongly encouraged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Things to considerer for treatment of sepsis

A
  • need source control to eliminate infection rapidly
  • need early and aggressive antimicrobial therapy
  • need one or more drugs with in vitro activity against most likely pathogens
17
Q

to do within first 3 hours of presentation

A
  • measure lactate concentration
  • obtain blood cultures prior administration to antibiotics
  • administer broad spectrum antibiotics
  • administer crystallodids (LR) for sepsis induced hypotension or lactate over 4mmol
18
Q

to be completed within first 6 hours of presentation

A
  • apply vasopressors to maintain Mean arterial pressure 65 mmHG. add norepinephrine, then vasopressin, then epinephrine.
19
Q

Community acquired empiric treatment for sepsis pneumonia

A
  • Ceftriaxone plus azithromycin/ respiratory FQ
20
Q

Community acquired empiric treatment for urinary tract sources

A
  • 3rd of 4th gen cephalosporin with or without aminoglycoside
  • Pip/Tazo with or without aminoglycoside
  • Fluoroquinolone (concern for resistance)
21
Q

Community acquired empiric therapy for suspected intra-abdominal source

A
  • Pip/Tazo
  • Carbapenem
  • 3rd or 4th generation cephalosporin + metronidazole
  • Ciprofloxacin or Levofloxacin + metronidazole
22
Q

Community acquired suspected skin and soft-tissue infection empiric treatment

A
  • vancomycin
  • Linezolid
  • Daptomycin
23
Q

Hospital-acquired infection from suspected pneumonia empiric therapy

A
  • Antipseudomonal Beta-Lactam + aminoglycoside or antipseudomonal FQ + Vanc or linezolid
24
Q

Hospital-acquired suspected urinary tract source (P. aeruginosa) empiric therapy

A
  • cefepime + aminoglycoside (tobra) or FQ

- Pip/Tazo + aminoglycoside (tobramycin) or FQ

25
Q

Hospital acquired into-abdominal suspected source empiric therapy

A
  • Pip/Tazo

- Carbapenem (not ertapenem)

26
Q

Hospital-acquired infections in neutropenic patients empiric treatment

A
  • pip/tazo plus or minus aminoglycoside
  • antipseudomonal carbapenem plus or minus aminoglycoside
  • ceftazidime or cefepime plus or minus aminoglycoside
27
Q

Thermal injury to at least 20% of bod area empiric therapy

A
  • antipseudomonal Beta-lactam + aminoglycoside + vanc
28
Q

Suspicion of sepsis from indwelling vascular catheter infections

A
  • vancomycin
  • daptomycin
  • linezolid
29
Q

duration of therapy for sepsis

A

7-10 days, longer if little

30
Q

guidelines for starting and stopping antibiotics based on PCT concentrations

A
  • stopping antibiotics when less than 0.25 PCT

- increase concentration compared to peak and 0.5mg ML consider switching antibiotics